SWX:NOVNPharmaceuticals
Novartis Expands US Radioligand Network With New Denton Cancer Facility
Novartis (SWX:NOVN) plans to build a new radioligand therapy manufacturing facility in Denton, Texas.
The plant will expand US production capacity for next generation cancer treatments.
The project is expected to create specialized jobs and support a more resilient domestic supply chain.
For you as an investor, this move highlights how Novartis is leaning further into radioligand therapies, a targeted cancer treatment area that has drawn growing interest in oncology. The Denton site adds to...